Justine Yang Bruce (Justine Y Bruce)

Publication Activity (10 Years)

Years Active: 2022-2024
Publications (10 Years): 7

Top Topics

Replacement Therapy

Drug Administration

Top Venues

Cancer research

Current treatment options in oncology

Radiographics : a review publication of the Radiological Society of North America, Inc

This page only lists publications with an associated author ORCID identifier.

Publications

Kourtney L Kostecki, Mari Iida, Bridget E Crossman, Ravi Salgia, Paul M Harari, Justine Yang Bruce, Deric L Wheeler
Immune Escape Strategies in Head and Neck Cancer: Evade, Resist, Inhibit, Recruit. Cancers 16 (2) (2024)
Kourtney L Kostecki, Mari Iida, Bridget E Crossman, Ravi Salgia, Paul M Harari, Justine Yang Bruce, Deric L Wheeler
Immune Escape Strategies in Head and Neck Cancer: Evade, Resist, Inhibit, Recruit. Cancers 16 (2) (2024)
Gregory D Avey, Ian J Koszewski, Mohit Agarwal, Levi A Endelman, Marin A McDonald, Adam R Burr, Justine Yang Bruce, Lauren Penn, Tabassum A Kennedy
Sinonasal Tumors: What the Multidisciplinary Cancer Care Board Wants to Know. Radiographics : a review publication of the Radiological Society of North America, Inc 44 (10) (2024)
Kourtney L Kostecki, Mari Iida, Bridget E Crossman, Ravi Salgia, Paul M Harari, Justine Yang Bruce, Deric L Wheeler
Immune Escape Strategies in Head and Neck Cancer: Evade, Resist, Inhibit, Recruit. Cancers 16 (2) (2024)
Kourtney L Kostecki, Mari Iida, Anne L Wiley, Stanley Kimani, Bridget Mehall, Kaitlin Tetreault, Roxana Alexandridis, Menggang Yu, Seungpyo Hong, Ravi Salgia, Justine Yang Bruce, Raymond B Birge, Paul M Harari, Deric L Wheeler
Dual Axl/MerTK inhibitor INCB081776 creates a proinflammatory tumor immune microenvironment and enhances anti-PDL1 efficacy in head and neck cancer. Head & neck (2023)
Alison E Smith, Stacia Chan, Zhiyong Wang, Asako McCloskey, Quinn Reilly, Jayden Z Wang, Hetika Vora Patel, Keiichi Koshizuka, Harris S Soifer, Linda Kessler, Ashley Dayoub, Victoria M Villaflor, Douglas R Adkins, Justine Yang Bruce, Alan L Ho, Cesar A Perez, Glenn J Hanna, Amaya Gasco Hernandez, Andrew Saunders, Stephen Dale, Jorge Silvio Gutkind, Francis Burrows, Shivani Malik
Tipifarnib potentiates the antitumor effects of PI3Kα inhibition in PIK3CA- and HRAS-dysregulated HNSCC via convergent inhibition of mTOR activity. Cancer research (2023)
Graham Campbell, Tiffany A Glazer, Randall J Kimple, Justine Yang Bruce
Advances in Organ Preservation for Laryngeal Cancer. Current treatment options in oncology 23 (4) (2022)